a program of the aga institute aga highlights · institutions and practices on sunday, june 3, 4 to...
Post on 18-May-2018
220 Views
Preview:
TRANSCRIPT
1
, . .
AGA HIGHLIGHTSThe Cornerstone of Programming at DDW®
A P R O G R A M O F T H E A G A I N S T I T U T E
3
TABLE OF CONTENTSAcknowledgments ........................................... 4
Plenaries and Business Meetings .................. 6
Special Named Sessions ................................ 7
AGA Zones ....................................................... 8
Saturday Sessions ......................................... 10
Sunday Sessions ........................................... 12
Monday Sessions .......................................... 14
Tuesday Sessions .......................................... 16
Cross-Societal Programming ......................... 18
Ticketed Sessions .......................................... 19
Poster Sessions ............................................. 20
Dear Colleagues,Welcome to Digestive Disease Week® (DDW) 2018! It's been a pleasure creating a great experience for you. We’re excited to share with you the AGA Highlights at DDW 2018 booklet, showcasing AGA’s wide array of educational and scientific programming being offered at DDW.
To reflect the growing, diverse interests of AGA members, two sections have undergone name changes this year. The Intestinal Disorders (ID) section is now the Basic & Clinical Intestinal Disorders (BCID) section. The Imaging & Advanced Technology (IAT) section is now the Imaging, Endoscopy & Advanced Technology (IEAT) section.
To ensure that the needs of both clinical practitioners and basic scientists are met at DDW 2018, the new Clinical Practitioner Zone and the Basic Science Zone will provide clinical practitioners and basic scientists with dedicated sessions in neighboring rooms at the convention center. Additionally, daily basic science themes will once again be spread across the four days of the meeting. Easily locate these sessions and navigate to other DDW sessions of interest by searching the new Clinical Practice Track or the Basic Science Track within the DDW Online Planner and Mobile App. AGA clinical practitioner and basic science lecture sessions are denoted with these special icons on pages 10– 17 of this booklet.
AGA will continue to offer daily poster tours on basic science and clinical topics in the Poster Hall. In tandem, DDW will hold ePoster presentations in the DDW ePosters Theater of the Poster Hall, allowing attendees further access to the latest science and research, free of charge!
Throughout the year, all four sponsoring societies have been focused on collaboration to reduce program overlaps. AGA council sections worked together to increase their cross-sectional descriptors to reduce redundancy. AGA will also host the joint DDW diversity session, Ensuring Diversity in Gastroenterology: Practical Approaches for GI Societies, Institutions and Practices on Sunday, June 3, 4 to 5:30 p.m. AGA and SSAT have partnered to host the Academic Debates on Monday, June 4, 3:45 to 5 p.m.
If you have not already registered for DDW, we encourage you to do so today. You can view detailed information about the meeting and register online at www.ddw.org. We look forward to seeing you in Washington, D.C.
Sincerely,
Maria T. Abreu, MD, AGAF AGA Institute Council Chair
Rhonda F. Souza, MD, AGAF AGA Institute Council Chair-Elect
Save the Date: DDW® 2019May 18–21, 2019 • Exhibit Dates: May 19–21, 2019 • San Diego, CA
For the most up-to-date information on sessions, please visit www.ddw.org.
2 3
4 5
Thank You to Our CouncilThank you to the AGA Institute Council for sponsoring this publication and for continuing to promote the highest-quality scientific knowledge for GI clinicians and researchers.
A Note to Our ReviewersThe AGA Institute Council thanks you for your commitment to our abstract review process. Without your time and dedication, we would not be able to provide our attendees with such robust abstract programming.
AGA Section CouncillorsThank you to the AGA section councillors who have provided their advice and recommendations, assisting the section leaders with section-sponsored programming.
If you wish to become involved in council activities, please contact agacouncil@gastro.org with your interest.
Basic & Clinical Intestinal DisordersGary D. Wu, MD
Cellular & Molecular Gastroenterology Charalabos Pothoulakis, MD
Clinical Practice Amnon Sonnenberg, MD, MSc
Esophageal, Gastric & Duodenal Disorders Nicholas J. Shaheen, MD, MPH, AGAF
Gastrointestinal Oncology Randall W. Burt, MD, AGAF
Growth, Development & Child Health Deborah L. Gumucio, PhD
Imaging, Endoscopy & Advanced Technology Michael B. Wallace, MD, MPH, AGAF
Immunology, Microbiology & Inflammatory Bowel Diseases Claudio Fiocchi, MD
Liver & Biliary Scott L. Friedman, MD
Microbiome & Microbial Diseases in the Gastrointestinal Tract Jeffrey I. Gordon, MD
Neurogastroenterology & Motility Richard W. McCallum, MD, AGAF
Obesity, Metabolism & Nutrition Lee M. Kaplan, MD, PhD, AGAF
Pancreatic Disorders Suresh T. Chari, MD
Maria T. Abreu, MD, AGAF, Chair Rhonda F. Souza, MD, AGAF, Chair-Elect
Basic & Clinical Intestinal DisordersWayne I. Lencer, MD, AGAF, ChairJoseph A. Murray, MD, AGAF, Vice Chair
Cellular & Molecular GastroenterologyLinda C. Samuelson, PhD, ChairJason Cornick Mills, MD, PhD, AGAF, Vice Chair
Clinical Practice Joel H. Rubenstein, MD, AGAF, ChairPaul Moayyedi, MD, PhD, AGAF, Vice Chair
Esophageal, Gastric & Duodenal DisordersJohn Y. Kao, MD, AGAF, ChairIkuo Hirano, MD, AGAF, Vice Chair
Gastrointestinal OncologyJohn P. Lynch, MD, PhD, ChairAndrew T. Chan, MD, MPH, AGAF, Vice Chair
Growth, Development & Child Health Maria M. Oliva-Hemker, MD, ChairMark Ronald Frey, PhD, Vice Chair
Imaging, Endoscopy & Advanced TechnologyJohn M. DeWitt, MD, AGAF, ChairJacques Van Dam, MD, PhD, AGAF, Vice Chair
Immunology, Microbiology & Inflammatory Bowel DiseasesMark S. Silverberg, MD, PhD, ChairUma Mahadevan, MD, AGAF, Vice Chair
Liver & BiliaryKenneth E. Sherman, MD, PhD, AGAF, ChairVijay Shah, MD, Vice Chair
Microbiome & Microbial Diseases in the Gastrointestinal TractEugene B. Chang, MD, AGAF, ChairTor Christopher Savidge, PhD, Vice Chair
Neurogastroenterology & MotilityJohn W. Wiley, MD, ChairLin Chang, MD, AGAF, Vice Chair
Obesity, Metabolism & NutritionDennis D. Black, MD, AGAF, ChairSandeep K. Gupta, MD, AGAF, Vice Chair
Pancreatic DisordersSanthi Swaroop Vege, MD, MBBS, DM, AGAF, FACG, FACP, ChairStephen J. Pandol, MD, Vice Chair
4 5
Acknowledgments
2018 AGA Institute Council Section Research Mentor Award RecipientsEach year, the council awards individuals for their achievements as outstanding mentors in specific areas of research. Congratulations to the following 2018 recipients. Please see pages 10–17 for details about the presentation of awards.
Committee-Sponsored SymposiaThank you to the following 17 AGA committees, centers and organizational partners that have developed and planned 29 AGA Committee-Sponsored Symposia at DDW 2018.
• AGA Biosimilars Advisory Panel • AGA Center for Diagnostics & Therapeutics• AGA Center for GI Innovation & Technology (CGIT)• AGA Center for Gut Microbiome Research
& Education• AGA Trainee & Early Career Committee• Clinical Guidelines Committee • Clinical Practice Updates Committee• Diversity Committee
• Education & Training Committee• Ethics Committee • Government Affairs Committee • International Committee • Practice Management & Economics Committee• Quality Measures Committee • Research Policy Committee • Rome Foundation • Women's Committee
Acknowledgments
6 7
The AGA Institute Council works with other societies and donor families to develop additional invited-speaker sessions.
6 7
AGA Presidential PlenaryMonday, June 4, 10 a.m.–NoonAGA will present an engaging plenary program through a blended series of abstract presentations and invited-speaker talks by Ikuo Hirano, MD, AGAF; David A. Lieberman, MD, AGAF; and Maria T. Abreu, MD, AGAF, on the topics of eosinophilic esophagitis, colorectal cancer and IBD, respectively. There will also be a brief address from AGA Institute President Sheila E. Crowe, MD, AGAF. (Ballroom A)
AGA Basic Science PlenarySunday, June 3, 4–5:30 p.m.This year’s basic science plenary will feature six abstracts covering topics in intestinal injury/infection, microbes and the enteric nervous system, and gastric cancer. (Room 103)
Distinguished Abstract PlenariesSaturday, June 2–Tuesday, June 5AGA Institute Council sections will host plenaries featuring top-scoring abstracts submitted to their section. Please refer to pages 10–17 for a complete listing of these sessions.
AGA Business MeetingMonday, June 4, 2–3 p.m.(Room 156)
Section Business MeetingsSelect council sections will host business meetings during DDW. These meetings are open to all AGA members and provide an opportunity to meet the section leaders and discuss section programming and initiatives. Please refer to the DDW Online Planner and Mobile App for more details.
DDW Late-Breaking AbstractsHear the latest, novel and groundbreaking research in basic and clinical science.
Basic Science Late-Breaking Abstract PlenarySunday, June 3, 2–3:30 p.m. (Room 146A)
Clinical Science Late-Breaking Abstract PlenaryTuesday, June 5, 10–11:30 a.m. (Room 146A)
Josephine and Michael Camilleri, MD, Lecture: Pharmacogenomics and Drug Treatment of Functional Motility and Sensation DisordersSaturday, June 2, 10–11:30 a.m.(Room 103)
Morton I. Grossman Distinguished Lectureship — Stressed Hepatocytes Incite Inflammation: Nano-Vesicles With Mega ImpactSaturday, June 2, 2–3:30 p.m. (Room 103)
Alternative and Complimentary Approaches for the Treatment of IBD: Evidence From Cochrane ReviewsSaturday, June 2, 4–5:30 p.m.(Ballroom A)
Donald O. Castell, MD, Lecture: Concepts and Controversies in the Management of Esophageal DisordersSaturday, June 2, 4–5:30 p.m.(Room 207)
Frances and Don W. Powell, MD, Lecture: Innate Immune Signaling at Mucosal SurfacesSaturday, June 2, 4–5:30 p.m.(Room 103)
Funderburg Symposium: Recent Advances in the Understanding and Management of Gastric CancerSunday, June 3, 8-9:30 a.m.(Room 103)
GRG Spring Symposium: Towards a New Generation of Ecologically Friendly AntibioticsSunday, June 3, 10–11:30 a.m.(Room 102A)
The Dr. Charles S. Lieber Lecture — Mechanisms of Autoimmune Associated Liver Injury: How Are PBC, PSC and Autoimmune Hepatitis Alike and Different?Sunday, June 3, 10–11 a.m.(Room 140)
Kiron and Kamala Das Symposium — Therapeutic Drug Monitoring: Do We Have a Consensus?Sunday, June 3, 2–3:30 p.m.(Ballroom A)
Kristin and David Peura, MD, Lecture: Celebrating the Successes of H. pylori DiscoverySunday, June 3, 2-3:30 p.m.(Room 146B)
Rodger Haggitt Gastrointestinal Pathology Society Symposium — Understanding Your Pathology Report and What to Do Next: Challenging Topics and Their Clinical Relevance Sunday, June 3, 2–3:30 p.m.(Room 151B)
The Charles M. Mansbach, II, MD, Memorial Lecture: Microbiome and Host MetabolismSunday, June 3, 4–5:30 PM (Room 144)
Farron and Martin Brotman, MD, Lecture — Monitoring for Dysplasia in IBD: Who, What, When and HowMonday, June 4, 8–9:30 a.m.(Ballroom A)
AGA Emmet B. Keeffe Symposium — Hepatitis D: Forgotten but Not LostMonday, June 4, 10–11:30 a.m.(Room 145B)
AGA Institute–Rome Foundation Lectureship: Gut Microbiota and Functional Gastroenterology Disorders (Disorders of Gut-Brain Interactions)Monday, June 4, 2–3:30 p.m.(Room 146AB)
Plenaries and Business Meetings Special Named Sessions
The Best of DDW 2018Tuesday, June 5, 2–4 p.m.Society leaders will review the “best of the best” science from each of the four sponsoring societies presented at DDW 2018. (Ballroom A)
8 98
AGA will feature clinical practice and basic science sessions specifically targeting clinical practitioners and basic scientists, respectively, throughout DDW. For these and other related sessions at DDW, follow the Basic Science and Clinical Practice Tracks using DDW session planning resources. There is a plethora of opportunities for you to attend invited-speaker, oral and poster sessions and to network with leaders in the field.
AGA ZONES AGA ZONES
Time Saturday: Cell Stress Sunday: Microbiome
8–9:30 a.m. Pancreatic Acinar Cell Organelles: What Happens When They Fail? (Room 102B)
The Human Gut Microbiome: A Commitment to Moving Beyond Descriptions of Parts to Dissections of Function (Room 144)
10–11:30 a.m. Mechanisms of Intestinal Injury and Repair (Room 102B)
The Human Gut Microbiome: Developing Tools and Strategies for Manipulating Its Properties (Room 144)
2–3:30 p.m. Cellular Plasticity, Metaplasia and Tissue Repair (Room 102B)
MMDGT Town Hall Meeting: Hitchhiker’s Guide to the Microbial Universe With Jeff Gordon, MD, and Fellow Explorers (Room 144)
4–5:30 p.m. Cancer Therapeutics and Mechanisms of Resistance (Room 102B)
The Charles M. Mansbach, II, MD, Memorial Lecture: Microbiome and Host Metabolism (Room 144)
Time Monday: Stem Cells and Regenerative Medicine
Tuesday: Innate Mechanisms of Immunity
8–9:30 a.m. Metabolic/Nutritional Regulation of Intestinal Stem Cells (Room 102B)
Microbial-Induced Alterations of Intestinal Transport (Room 102B)
10–11:30 a.m. Stem Cell Biology (Room 102B) Intestinal Epithelial Cell Biology (Room 102B)
2–3:30 p.m. Gastrointestinal Stem Cell Plasticity (Room 102B)
IBD: Innate and Adaptive Lymphoid Activation and Regulation (Room 102B)
4–5:30 p.m. Tissue Engineering and Regenerative Medicine (Room 102B)
Microbial-Induced Mucosal Inflammation and Innate Immunity (Room 102B)
AGA Basic Science Themes To address the needs of this important group, the AGA Institute Council Basic Science Subcommittee developed daily basic science themes.
AGA Basic Science ZoneKeep an eye out for basic science sessions in neighboring rooms 101, 102A, 102B and 103, the Basic Science Zone, throughout the meeting.
AGA Basic Science SessionsAGA offers over 135 lecture and poster sessions targeted to basic scientists throughout the convention center across all four days of the meeting. AGA's lecture sessions are denoted with the icon on pages 10–17.
AGA Clinical Practitioner SessionsAGA offers over 115 lecture and poster sessions targeted to clinical practitioners throughout the convention center across all four days of the meeting. AGA's lecture sessions are denoted with the icon on pages 10–17.
Mark your schedule for the following must-see sessions:
AGA Clinical Practitioner ZoneBe on the lookout for clinical practitioner sessions in neighboring rooms 140, 145A, 145B, 146A, 146B and 146AB (Monday), the Clinical Practitioner Zone, throughout the meeting.
DDW Basic Science Quick Shots and ReceptionSaturday, June 2, 4–5:30 p.m.The 20 early career recipients of the DDW 2018 Basic Science Travel Award will provide a synopsis of their research through short "quick-fire" presentations. A reception will immediately follow the session from 5:30 to 6:30 p.m. Network with fellow basic science colleagues and early career researchers over light refreshments. (Room 143)
Battle of the Heavyweights: Controversies in Clinical Practice From IBD to NASHSaturday, June 2, 10–11:30 a.m.(Room 145A)
Donald O. Castell, MD, Lecture: Concepts and Controversies in the Management of Esophageal DisordersSaturday, June 2, 4–5:30 p.m.(Room 207)
Maneuvering MACRA: Compliance and ResourcesSunday, June 3, 2–3:30 p.m.(Room 145B)
Detection, Diagnosis and Management of Pancreatic Cysts in 2018Monday, June 4, 8–9:30 a.m.(Room 201)
Impact of America's Opioid Epidemic on the Practice of GastroenterologyMonday, June 4, 2–3:30 p.m.(Room 144)
It's Still a Free Country: Choice in IBD ManagementMonday, June 4, 2–3:30 p.m. (Ballroom A)
2018 AGA Guideline Highlights: Gastric Intestinal Metaplasia, EoE, OIC and MoreTuesday, June 5, 8–9:30 a.m.(Room 144)
CRC Screening Cage Matches: The SequelTuesday, June 5, 2–3:30 p.m.(Room 145A)
Future of Biosimilars in GastroenterologyTuesday, June 5, 2–3:30 p.m.(Room 144)
9
10
8–9:30 a.m. 10–11:30 a.m.BCID ��Epithelial Ion, Water and Nutrient Absorption (Room 101)
CMG �Cellular Plasticity in Regeneration and Metaplasia (Room 103) �Stem Cells in the Origin and Progression of Cancer (Room 101)
CP�Caring for Inflammatory Bowel Disease: Quality Matters (Room 207)
�Endoscopic Performance Metrics: Are Quality Measures High Quality? (Room 144)
�Missed Lesions and Appropriate Follow-Up of Screening and Surveillance (Room 207)
CSS�Battle of the Heavyweights: Controversies in Clinical Practice From
IBD to NASH (Room 145A)
�Tales From the Front Lines: What Defines a "Quality" Gastroenterologist? (Room 145B)
EGD�Advances in the Diagnosis and Management of Barrett's Esophagus
(Room 151A)
H. pylori Epidemiology, Diagnosis and Treatment (Room 206)
GDCH�Functional Pediatric Disorders (Room 151B)
�Mechanisms of Intestinal Injury and Repair (Room 102B)
GIONC �Inflammation and Cancer: Deeper Insights From Molecular Pathways and Genetic Landscapes (Room 102A)
�Innovating Physiologically Relevant Gastrointestinal-Cancer Models (Room 102A)
IEAT Advances in Imaging of the Pancreatic Disease (Room 145B)
IMIBD IBD Epidemiology and Natural History (Ballroom A)Can We Predict Who Will Get IBD? Can We Prevent It? Answers From
Human Studies (Room 206)
IBD: Adverse Events Related to Therapy (Ballroom A)
LB �NAFLD and NASH (Room 140) A Day of Hepatobiliary Consults (Room 140)
MMDGT
�Clinical Research Design for Microbial-Based Interventions (Room 151B)
�Clostridium difficile Colitis: Pathogenesis, Diagnosis, Management and Therapy (Room 146B)
�Microbiome and Microbial Diseases in the Gastrointestinal Tract (MMDGT) Section Distinguished Abstract Plenary (Room 201)
NGM��Esophageal Motility and Dysmotility (Room 145A)
��Functional Dyspepsia, Nausea and Vomiting (Room 201)��Josephine and Michael Camilleri, MD, Lecture: Pharmacogenomics and Drug
Treatment of Functional Motility and Sensation Disorders (Room 103)
OMN �Apples and Pears: Understanding the Origins of Obesity Phenotypes (Room 151A)
PAN ��Pancreatic Acinar Cell Organelles: What Happens When They Fail? (Room 102B) ��Chronic Pancreatitis Controversies (Room 144)
KEY n BCID – Basic & Clinical Intestinal Disorders
n CMG – Cellular & Molecular Gastroenterology
n CP – Clinical Practice
n CSS – Committee-Sponsored Symposium
n EGD – Esophageal, Gastric & Duodenal Disorders
n GDCH – Growth, Development & Child Health
n GIONC – Gastrointestinal Oncology
n IEAT – Imaging, Endoscopy & Advanced Technology
n IMIBD – Immunology, Microbiology & Inflammatory Bowel Diseases
11
2–3:30 p.m. 4–5:30 p.m.
BCID ��Epithelial Barrier Functions II (Room 209)
��Diarrhea and Irritable Bowel Syndrome – New Advances (Room 140)
�Frances and Don W. Powell, MD, Lecture: Innate Immune Signaling at Mucosal Surfaces (Room 103)
CMG �Cellular Plasticity, Metaplasia and Tissue Repair (Room 102B)
CP �Randomized Trials of Extending the Reach of Colorectal Cancer Screening (Room 201)
CSS�Innovative Trial Designs in Gastrointestinal Drug Development: Why Trials
Succeed and Fail (Room 145B)
�Obesity for the Gastroenterologist: The Why and How To (Room 146A)
EGD �Donald O. Castell, MD, Lecture: Concepts and Controversies in the Management of Esophageal Disorders (Room 207)
GDCH
GIONC �New Frontiers in Gastrointestinal-Cancer Genomics (Room 102A) �Cancer Therapeutics and Mechanisms of Resistance (Room 102B)
IEATAdvanced Endoscopy of the Biliary Tract (Room 146B)
Advances in Colorectal Polyp Detection (Room 207)�Advances in Imaging and Therapy of the Pancreas and Biliary System
(Room 144)
IMIBDIBD: Microbiome (Room 101)
Uncontrolled Therapeutic Observations and Disease Complications in IBD (Ballroom A)
LB
MMDGT �Microbiome and Cancer (Room 201)�Gut Feelings: Microbiome-Gut-Brain Interactions in
Neurodevelopmental Disease (Room 147)
�Obesity and the Microbiome (Room 102A)
NGM��Central Neuromodulators for Chronic Gastrointestinal Pain and Functional
Gastrointestinal Disorders (Disorders of Gut-Brain Interaction: A Rome Foundation Working Team Report) (Room 140)
��Gastroparesis and Small Intestine Dysmotility (Room 145A)
��Enteric Neurobiology: Cell and Molecular Biology (Room 101)
OMN �Dietary Management of Pediatric Gastrointestinal Diseases (Room 151A)
PAN ��Pancreatic Cystic Neoplasms, IPMN and Neuroendocrine Tumors (Room 144)
n LB – Liver & Biliary
n MMDGT – Microbiome & Microbial Diseases
in the Gastrointestinal Tract
n NGM – Neurogastroenterology & Motility
n OMN – Obesity, Metabolism & Nutrition
n PAN – Pancreatic DisordersTo search for sessions and abstracts or to customize your itinerary, visit www.ddw.org/resources.
SATURDAY, JUNE 2 SATURDAY, JUNE 2
– Plenary
– Special Named Session
– Basic Science Session
– Clinical Practitioner Session
– Research Mentor Award Presentation
12
8–9:30 a.m. 10–11:30 a.m.BCID ��Epithelial Junctions and Barrier Function (Room 101) ��Diarrheal and Autoimmune Disorders of the Intestinal Mucosa
(Room 101)
CMG �Organoid Models of Gastrointestinal Disorders (Room 102A)
CP �The Rising Incidence of Colorectal Cancer Among Young Adults: Who, Why and What Should We Do About It? (Room 201)
�Screening for Esophageal Adenocarcinoma: Practical Solutions to the Challenge of Primary Screening (Room 209)
CSS�AGA-JSGE Joint Symposium (Room 146B)
�Practical Guidelines for the Physician Innovator (Room 145B)
EGD�Advances in Extraesophageal Manifestations of GERD (Room 140)
�Funderburg Symposium: Recent Advances in the Understanding and Management of Gastric Cancer (Room 103)
�Advances in the Management of Eosinophilic Esophagitis (Room 151A)
�New Concepts in the Pathogenesis of Barrett's Esophagus (Room 102B)
GDCH�Developmental Biology of the Gastrointestinal Tract
(Room 102B)
�Management of Pediatric IBD (Room 151A)
GIONC �GRG Spring Symposium: Towards a New Generation of Ecologically Friendly Antibiotics (Room 102A)
IEAT Infection Transmission in Gastrointestinal Endoscopy (Room 145A)
IMIBD Safety Signals in the Biologic Era (Ballroom A) IBD: Clinical Dilemmas: From Ivory Tower to Daily Practice (Ballroom A)
LB �Complications of Cirrhosis and Portal Hypertension (Room 145A)
�The Dr. Charles S. Lieber Lecture — Mechanisms of Autoimmune Associated Liver Injury: How Are PBC, PSC and Autoimmune Hepatitis Alike and Different? (Room 140)
MMDGT�The Human Gut Microbiome: A Commitment to Moving
Beyond Descriptions of Parts to Dissections of Function (Room 144)
�The Human Gut Microbiome: Developing Tools and Strategies for Manipulating Its Properties (Room 144)
NGM ��Constipation and Other Functional Colonic Syndromes (Ballroom B) ��Gut Microbiome, Sensory Mechanisms and Barrier Function (Room 103)
OMN �Endoscopic and Surgical Therapies of Obesity and Metabolic Disorders (Ballroom B)
PAN ��Pancreatic Cancer: Novel Diagnostics and Precision Medicine (Room 151B)
��Basic Themes in Pancreatic Disorders (Room 151B)
��Pancreatic Disorders (PAN) Section Distinguished Abstract Plenary (Room 201)
13
2–3:30 p.m. 4–5:30 p.m.
BCID��Immune Check Point Inhibitor Induced Diarrhea
(Room 145B)
��Tuft and Paneth Cells: Dueling Roles in Innate and Acquired Immunity (Room 101)
CMG �Organoids and Engineered Organ Systems (Room 101)
CP�How to Manage Difficult Gastroenterology Consultations (Room 140)
�Management of Functional Gastrointestinal Disorders (Ballroom B)
CSS
�Future of Research in Digestive Diseases (Room 103)
�Maneuvering MACRA: Compliance and Resources (Room 145B)
�Teaching Motility and Nutrition — How I Do It (Sharing Different Perspectives) (Room 145A)
�Best of AGA at DDW in Chinese (Room 151B)
�Difficult Conversations: Navigating People, Negotiations, Promotions and Complications (Room 145A)
EGD�Advances in the Diagnosis of GERD (Room 201)
�Kristin and David Peura, MD, Lecture: Celebrating the Successes of H. pylori Discovery (Room 146B)
�Advances in the Therapy of GERD (Room 151A)
�Scientific Advances in Eosinophilic Esophagitis (Room 102B)
GDCH
GIONC �Biomarkers in GI Cancer (Room 102A) �Screening and Prevention of GI Cancer (Room 207)
IEAT Advances in Endoscopic Diagnosis and Staging of Inflammatory Bowel Disease (Ballroom B)
IMIBDKiron and Kamala Das Symposium — Therapeutic Drug Monitoring:
Do We Have a Consensus? (Ballroom A)
IBD: Cytokines, Signaling and Receptors (Room 102B)
Old School Therapies: Aminosalicylates to Acupuncture (Ballroom A)
LB
MMDGT �MMDGT Town Hall Meeting: Hitchhiker’s Guide to the Microbial Universe With Jeff Gordon, MD, and Fellow Explorers (Room 144)
�The Charles M. Mansbach, II, MD, Memorial Lecture: Microbiome and Host Metabolism (Room 144)
NGM ��Irritable Bowel Syndrome: Clinical (Room 201)
OMN �Short Bowel Syndrome: Is a "Little" Bowel Still a "Big" Deal? — An Update (Room 102A)
PAN ��Pancreatic Cancer: Risk Factors, Biology, Diagnosis and Clinical Therapeutics (Room 151A) ��Clinical Acute Pancreatitis (Room 140)
SUNDAY, JUNE 3 SUNDAY, JUNE 3
KEY n BCID – Basic & Clinical Intestinal Disorders
n CMG – Cellular & Molecular Gastroenterology
n CP – Clinical Practice
n CSS – Committee-Sponsored Symposium
n EGD – Esophageal, Gastric & Duodenal Disorders
n GDCH – Growth, Development & Child Health
n GIONC – Gastrointestinal Oncology
n IEAT – Imaging, Endoscopy & Advanced Technology
n IMIBD – Immunology, Microbiology & Inflammatory Bowel Diseases
12 13
Certificates of RecognitionEarly career GIs selected for abstract presentation within select sections will be recognized in AGA sessions throughout the entirety of the meeting.
n LB – Liver & Biliary
n MMDGT – Microbiome & Microbial Diseases
in the Gastrointestinal Tract
n NGM – Neurogastroenterology & Motility
n OMN – Obesity, Metabolism & Nutrition
n PAN – Pancreatic DisordersTo search for sessions and abstracts or to customize your itinerary, visit www.ddw.org/resources.
– Plenary
– Special Named Session
– Basic Science Session
– Clinical Practitioner Session
– Research Mentor Award Presentation
2–3:30 p.m. 4–5:30 p.m.
BCID�Celiac Disease: Treatment and Monitoring (Room 151A)
�Intestinal Inflammation, Fibrosis and Regeneration (Room 102A)
�Celiac Disease: Diagnosis Best Practices (Room 145A)
�Microbial Pathogens and Toxins of the Intestine and Colon (Room 151B)
CMG ��Gastrointestinal Stem Cell Plasticity (Room 102B) ��Cellular & Molecular Gastroenterology (CMG) Section Distinguished Abstract Plenary and Section Business Meeting (Room 102A)
CP �Impact of America's Opioid Epidemic on the Practice of Gastroenterology (Room 144)
CSS
�AGA Institute–Rome Foundation Lectureship: Gut Microbiota and Functional Gastroenterology Disorders (Disorders of Gut-Brain Interactions) (Room 146AB)
�Microbiome Active Learning Session 300: The Gut Microbiome and Its Metabolome in Health and Disease (Room 145A)
�Minorities and Immigrants: Access to Care and Contributions to the Advancement of Gastroenterology (Room 151B)
�Strategies for a Successful Career: Wellness, Empowerment, Leadership and Resilience (Room 101)
�Advancing Clinical Practice: Gastroenterology Fellow-Directed Quality-Improvement Projects (Room 151A)
�Utilizing Quality Care Measures in Colonoscopy to Ensure Ethical Clinical Practice (Room 207)
EGD �Update on NSAIDs Bleeding (Room 144)
GDCH �Tissue Engineering and Regenerative Medicine (Room 102B)
GIONC �Hereditary Colon Cancer and Cancer Predisposition (Room 140) �Gastrointestinal Oncology (GIONC) Section Distinguished Abstract Plenary (Room 103)
IEAT
IMIBD ��It's Still a Free Country: Choice in IBD Management (Ballroom A) ��Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Distinguished Abstract Plenary (Ballroom A)
LB �Alcoholic Liver Disease (Room 145B)
MMDGT �Role of the Gut Microbiome in Immune and Inflammatory Diseases (Room 103) �Diet and Microbiome (Room 101)
NGM�Sensory Neurobiology Including Visceral Nociception/Pain and
Neuroimmunology (Neurogenic Inflammation and Interactions With the Microbiome) (Room 145B)
�Neurogastroenterology & Motility (NGM) Section Distinguished Abstract Plenary and Section Business Meeting (Room 201)
OMN �Intestinal Failure and Nutritional Support (Room 140)
PAN ��Walled-Off Necrosis in Acute Pancreatitis: Uncertainties and Need for Future Research (Room 201)
14
8–9:30 a.m. 10–11:30 a.m.BCID �Breeching Tolerance (Room 102A) �Celiac Epidemiology (Room 140)
CMG ��Metabolic/Nutritional Regulation of Intestinal Stem Cells (Room 102B) ��Stem Cell Biology (Room 102B)
CP
CSS�Medical Foods and Nutrition Therapy for Gastroenterology Disorders
(Room 151A)
�Team and Staff Safety, Culture and Efficiency (Room 145B)
�AGA's O Melhor da DDW (Room 102A)
�Exploring Academic Career Pathways in Gastroenterology and Hepatology (Room 151B)
EGD �Update on the Management of Eosinophilic Esophagitis (Room 144)
GDCH �Pediatric IBD (Room 151B)
GIONC�Stem Cells and Cancer (Room 101)
�The Future of Barrett's Esophagus Screening, Risk Stratification, and Surveillance: Updates From the NCI Barrett’s Esophagus Translational Research Network (Room 140)
�Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis and Therapy (Room 103)
�The Gastrointestinal-Cancer Microbiome — Which Came First? (Room 101)
IEAT Detection, Diagnosis and Management of Pancreatic Cysts in 2018 (Room 201)
IMIBD��Farron and Martin Brotman, MD, Lecture — Monitoring for Dysplasia in IBD:
Who, What, When and How (Ballroom A)
��Visceral Fat and Obesity in Inflammatory Bowel Disease (Room 103)
��IBD: Genomics and Gene Function (Room 201)
��The Role of Endoscopy in IBD: 2018 (Room 146AB)
LB �AGA Emmet B. Keeffe Symposium — Hepatitis D: Forgotten but Not Lost (Room 145B)
MMDGT �Defining the Healthy Gut Microbiome (Room 145A)
NGM�Motility Matters 2018: An Interactive Case-Based and Panel Discussion
on Current Understanding and Management of Gastrointestinal Motility Disorders (Room 146AB)
�Brain-Gut Axis (Including Neuroimaging, Vagal Pathways and Neurobiology of Satiety, Obesity and Metabolic Disorders) (Room 144)
OMN �Anemia and Gastrointestinal Disorders (Room 145A)
PAN ��IG G4 Disease: Is This a New Entity? (Room 151A)
15
MONDAY, JUNE 4 MONDAY, JUNE 4
KEY n BCID – Basic & Clinical Intestinal Disorders
n CMG – Cellular & Molecular Gastroenterology
n CP – Clinical Practice
n CSS – Committee-Sponsored Symposium
n EGD – Esophageal, Gastric & Duodenal Disorders
n GDCH – Growth, Development & Child Health
n GIONC – Gastrointestinal Oncology
n IEAT – Imaging, Endoscopy & Advanced Technology
n IMIBD – Immunology, Microbiology & Inflammatory Bowel Diseases
14 15
n LB – Liver & Biliary
n MMDGT – Microbiome & Microbial Diseases
in the Gastrointestinal Tract
n NGM – Neurogastroenterology & Motility
n OMN – Obesity, Metabolism & Nutrition
n PAN – Pancreatic DisordersTo search for sessions and abstracts or to customize your itinerary, visit www.ddw.org/resources.
– Plenary
– Special Named Session
– Basic Science Session
– Clinical Practitioner Session
– Research Mentor Award Presentation
16
8–9:30 a.m. 10–11:30 a.m.BCID
�Basic Mechanisms of Tissue Repair (Room 151B)
�Microbial-Induced Alterations of Intestinal Transport (Room 102B)
CMG ��Signaling Pathways Regulating GI Homeostasis and Disease (Room 102A) ��Intestinal Epithelial Cell Biology (Room 102B)
CP�Chronic Diarrhea and IBS: Current Knowledge and Update on
Management Strategies (Room 140)
�Serrated Neoplasia of the Colon: Current Concepts and Best Practice (Room 144)
CSS�2018 AGA Guideline Highlights: Gastric Intestinal Metaplasia, EoE, OIC and
More (Room 144)
�AGA Academy of Educators Plenary Session: Valuing Education Leadership (Room 151A)
�AGA's Lo Mejor de DDW (Room 151B)
�Best of UEG Week at DDW (Room 146B)
�Innovative Solutions in Curriculum Development for Training Programs (Room 102A)
�Technology Opportunities in Gastroenterology Practice: How to Make Technology Work for You (Room 145A)
EGD �Advances in the Management of Barrett's Esophagus (Room 146B) �Esophageal, Gastric & Duodenal Disorders (EGD) Section Distinguished Abstract Plenary (Room 201)
GDCH �Potpourri of Pediatric Gastroenterology (Room 140) �Pediatric Intestinal Inflammation: Basic Advances (Room 103)
GIONC�Colorectal Cancer Screening and Surveillance (Room 201)
�Tumor Microenvironment and Signaling Pathways (Room 101)
IEAT
IMIBD��Controlled Clinical Trials in Humans: Part I (Ballroom A)
��Epithelial Cell Function in Inflammation (Room 103)��Controlled Clinical Trials in Humans: Part II (Ballroom A)
LB �Clinical Biliary Tract Diseases (Room 145C) �Liver Disease in Pregnancy (Room 145B)
MMDGT �Environmental Impact on the Human Gut Microbiome (Room 145A) �The Microbiome-Gut-Brain Axis in Health and Disease (Room 101)
NGM
OMN �The Relationship Between Sleep Disorders and Gastrointestinal/Liver Disease (Room 151A)
PAN
17
2–3:30 p.m. 4–5:30 p.m.
BCID�Inflammatory, Proliferative and Adaptive Responses of the Intestinal
Epithelium (Room 101)
�Food Allergies and Sensitivities (Room 140)
�Microbial-Induced Mucosal Inflammation and Innate Immunity (Room 102B)
CMG ��Microbe Sensing and Inflammatory Signaling (Room 103) In Vivo Models of Gastrointestinal Disorders (Room 103)
CP�CRC Screening Cage Matches: The Sequel (Room 145A)
�Improving Access, Therapy and Cost. The Three Legged Stool of Microbial Transplant for C. difficile (Room 146A)
�There Will Be Blood. So How Do We Stop It? (Room 145A)
CSS �Future of Biosimilars in Gastroenterology (Room 144)
EGD �H. pylori Host Response/Mucosal Defense, Injury and Repair (Room 151A)
GDCH
GIONC �What's New in Neuroendocrine Tumors (Room 146B) �Hereditary Cancer Syndromes (Room 146B)
IEAT Imaging and Advanced Technology for Barrett's Esophagus (Room 144)
IMIBD��IBD Diagnostics and Disease Activity Assessment (Room 201)
��IBD: Innate and Adaptive Lymphoid Activation and Regulation (Room 102B)��Animal Models to Develop Therapies for IBD (Room 140)
LB
MMDGT �Biotics in Health and Disease (Room 101)
NGM
�Anorectal Dysmotility (Room 151A)
�Novel Mechanisms and Treatment in Irritable Bowel Syndrome (Room 145B)
�The Value of Impedance Measurements in Clinical Esophagology (Room 151B)
�Irritable Bowel Syndrome: Pathophysiology (Room 201)
OMN �Nutrient Absorption and Regulation of Intake (Room 145B)
PAN ��Clinical Chronic Pancreatitis (Room 151B)
TUESDAY, JUNE 5 TUESDAY, JUNE 5
KEY n BCID – Basic & Clinical Intestinal Disorders
n CMG – Cellular & Molecular Gastroenterology
n CP – Clinical Practice
n CSS – Committee-Sponsored Symposium
n EGD – Esophageal, Gastric & Duodenal Disorders
n GDCH – Growth, Development & Child Health
n GIONC – Gastrointestinal Oncology
n IEAT – Imaging, Endoscopy & Advanced Technology
n IMIBD – Immunology, Microbiology & Inflammatory Bowel Diseases
� AGA Board Review CourseTuesday, June 5, 1:30–5:30 p.m.This session, designed around content from DDSEP® 8, serves as a primer for third-year fellows preparing for the board exam as well as a review course for others wanting to test their knowledge. (Room 207)
16 17
n LB – Liver & Biliary
n MMDGT – Microbiome & Microbial Diseases
in the Gastrointestinal Tract
n NGM – Neurogastroenterology & Motility
n OMN – Obesity, Metabolism & Nutrition
n PAN – Pancreatic DisordersTo search for sessions and abstracts or to customize your itinerary, visit www.ddw.org/resources.
– Plenary
– Special Named Session
– Basic Science Session
– Clinical Practitioner Session
– Research Mentor Award Presentation
18 19
Focused Clinical Updates and Focused Research RoundtablesSunday, June 3, and Monday, June 4, 6:30–7:45 a.m.SESSION FEE: $75, includes continental breakfast LOCATION: Marriott Marquis
These sessions are designed to help you discuss the must-see clinical research and basic science abstracts accepted by AGA for presentation at DDW. Sessions are limited to 40 participants per session, so register today to secure your spot.
Sunday, June 3• Advances in Endoscopy Techniques (FC01)• Emerging Therapies: IBD (FC02)• Recent Advances in GERD Diagnosis and Therapy:
DDW 2018 (FC03)• Recent Advances in the Management of Barrett’s
Esophagus (FC04)• GI Cancer 2017: Models and Mechanisms (FC05)
Monday, June 4• Dietary Modifications of the Gut Microbiome (FC06)• Hereditary GI Cancers (FC07)• Management of Pancreatic Neoplasms (FC08) • Dietary Interventions in IBS (FR01)• Immunology in IBD (FR02)
DDW Breakfast-With-the-ExpertsSunday, June 3–Tuesday, June 5, 6:30–7:45 a.m.SESSION FEE: $75, includes continental breakfastLOCATION: Walter E. Washington Convention Center
DDW’s popular Meet-the-Professor format is offered in the morning too. Similar to the traditional lunch sessions, these are scholarly, dynamic discussions in an informal, small-group atmosphere. Space is limited — register today!
DDW Meet-the-Professor LuncheonsSunday, June 3–Tuesday, June 5, 12:30–1:45 p.m.SESSION FEE: : $75, includes boxed lunchLOCATION: Walter E. Washington Convention Center
Participate in scholarly, dynamic discussion in an informal, small-group atmosphere. Space is limited — register today!
Ticketed Sessions
18
Cross-Societal ProgrammingAGA, AASLD, ASGE, SSAT
Saturday, June 28–9:30 a.m.• Bariatrics: The Thick and the Thin of It (Room 143)
10–11:30 a.m.• Endoscopic, Surgical and Medical Management of NASH
(Room 143)
Sunday, June 38–9:30 a.m.• Multidisciplinary Management of Gastrointestinal and
Pancreatic Neuroendocrine Tumors (Room 143)
10–11:30 a.m.• Best Practices in Screening Colonoscopy (Room 143)
2–3:30 p.m.• Managing Bile Duct Injuries in the Modern Era: Scopes,
Wires and Surgery (Room 143)
4–5:30 p.m.• Training in Endoscopy (Room 143)
Monday, June 48–9:30 a.m.• Emergent Presentation of Colon and Rectal Cancers
(Room 143)
10–11:30 a.m.• Updates in Identification and Management of Liver Masses
(Room 143)
2–3:30 p.m.• Bariatric Endoscopy: The Future is Now (Room 150)
4–5:30 p.m.• Treating GI and Liver Disorders Through Manipulation of the
Microbiome (Room 143)
Tuesday, June 58–9:30 a.m.• Cannabinoids and Neurogastroenterology: A Weed for
Occam's Razor (Room 143)• Innovations in Health Care Delivery (Room 206)• Obesity: Metabolism and Nutrition (Room 146A)
10–11:30 a.m.• GE Junction Cancer: Prevention, Treatment
and Controversies (Room 143)
2–3:30 p.m.• Controversies in the Management of Gastric Metaplasia and
Cancer (Room 143)
Each year, the four sponsoring societies collaborate on sessions that cover broad topics for attendees.
DDW DIVERSITY SESSION AND RECEPTIONSunday, June 3, 4–5:30 p.m.Ensuring Diversity in Gastroenterology: Practical Approaches for GI Societies, Institutions and Practices
This session will highlight unique issues concerning diversity in GI societies, institutions and practices. A networking reception, jointly sponsored by all four societies, will immediately follow the session from 5:30 to 6:30 p.m. (Room 146A)
ACADEMIC DEBATESMonday, June 4, 3:45–5 p.m.Senior experts and trainees from AGA and SSAT will pair up to debate the latest hot-button issues in GI.
Jointly sponsored by AGA and SSAT. (Room 146)
Register for these AGA and DDW ticketed sessions online during the registration process. If you want to add these sessions to your existing registration, log back in to the Registration Resource Center.
AGA Postgraduate Course: From Abstract to RealitySaturday, June 2, 8:15 a.m.– 5:30 p.m., and Sunday, June 3, 8:30 a.m.–12:35 p.m.COURSE DIRECTORS: Lin Chang, MD, AGAF; Carl L. Berg, MD; and David Weinberg, MD
Attend this multi-topic course to get practical, useful information to push your practice to the next level. The 2018 course will provide a comprehensive look at the latest medical, surgical and technological advances over the past 12 months that aim to keep you up-to-date in a field that is rapidly changing. Each presenter will turn abstract ideas into concrete action items that you can immediately implement in your practice.
For complete course details, please visit the AGA website at pgcourse.gastro.org.
20 21
Saturday, June 2Basic & Clinical Intestinal Disorders• Cell Molecular Biology of Intestinal Barrier, Injury, Repair,
Fibrosis• Epithelial Ion, Water and Nutrient Absorption• Inflammation and GI Cancers• Microbes in Epithelial Function and Inflammation
Cellular & Molecular Gastroenterology• Gastric Neoplasms: Precursor Lesions and Biology• Genetic, Transcriptional and Epigenetic Mechanisms• Growth Factors in Cell Proliferation and Differentiation
Clinical Practice• Epidemiology of GI Disease• GI Cancer Epidemiology and Screening• Health Care Delivery• Health Disparities
Esophageal, Gastric & Duodenal Disorders• Eosinophilic Esophagitis: Clinical• Eosinophilic Esophagitis: Translational or Basic• GERD/Barrett's: Pathogenesis• GERD: Medical, Surgical and Endoscopic Therapies
Gastrointestinal Oncology• Biomarkers for Detection, Treatment and Prognosis of GI
Cancers I• Cancer Stem Cells and Circulating Tumor Cells• Canceromics: Cancer Genomics, Epigenomics,
Metabolomics, Proteomics and Systems Biology• Esophageal and Junctional Neoplasms: Precursor Lesions,
Biology, Diagnosis and Clinical Therapeutics• Inflammation and GI Cancers• Microbiome and Cancer• Pancreatic Cancer: Risk Factors, Biology, Diagnosis and
Clinical Therapeutics• Tumor Cell Biology, Immunology and Microenvironment
Growth, Development & Child Health• Food Intolerances, Allergy and Sensitivities• Genetics and Intestinal Disorders
• GI Tract Growth and Development: Basic and Translational Advances
• Pediatric Functional and Motility Disorders I• Pediatric IBD: Clinical and Translational Studies I• Pediatric Liver and Biliary Diseases• Pediatric Nutrition and Obesity Imaging, Endoscopy & Advanced Technology• Imaging of the GI Tract• Novel/Experimental Endoscopy
Immunology, Microbiology & Inflammatory Bowel Diseases• IBD: Adverse Events Related to Therapy• IBD: Comparative Effectiveness Studies• IBD: Controlled Clinical Trials in Humans• IBD: Diagnostics in IBD• IBD: Disease Complications
Liver & Biliary• Clinical Biliary Tract Disorders, Stone Diseases and Stone
Pathogenesis
Microbiome & Microbial Diseases in the Gastrointestinal Tract• Highlights of Microbiome Research
Neurogastroenterology & Motility• Diarrheal Diseases, Bacterial Overgrowth, Drug Induced and
Other Enteropathies• Gastroparesis and Small Intestinal Dysmotility• Irritable Bowel Syndrome: Pathophysiology
Obesity, Metabolism & Nutrition• Obesity: Basic and Mechanistic Studies• Obesity: Clinical and Epidemiological Studies
Pancreatic Disorders• Clinical Acute Pancreatitis
Sunday, June 3Basic & Clinical Intestinal Disorders• Celiac Disease and Gluten Related Disorders I• Intestinal Inflammation, Fibrosis and Regeneration• Irritable Bowel Syndrome
Cellular & Molecular Gastroenterology• Cancer Location, Biomarkers and Progression• Chemosensing in the GI Tract• GI Injury, Inflammation and Fibrosis• Receptor Signaling and Enteric Neuroscience
Clinical Practice• Epidemiology and Outcomes of Functional GI Disease• Health Economics• Medical Education
Esophageal, Gastric & Duodenal Disorders• Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis
and Therapy• GERD: Complications and Extra-Esophageal Presentations• GERD: Diagnostic Testing• Helicobacter pylori: Epidemiology, Diagnosis and Outcomes
Gastrointestinal Oncology• Colon Cancer Screening• Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis
and Therapy I• GI Cancer Research Models: Organoids, Engineered Cell and
Tissue Platforms and Animal Models• Metabolism, Obesity, Microbiome and Nutrition in GI Cancer
Pathogenesis• Molecular Mechanisms and Pathways in Carcinogenesis
and Metastasis: Bench to Bedside I
Growth, Development & Child Health• Pediatric IBD: Clinical and Translational Studies II
Imaging, Endoscopy & Advanced Technology• Confocal Endomicroscopy and Other Optical Sectioning
Techniques• Diagnostic and Therapeutic Applications I
Immunology, Microbiology & Inflammatory Bowel Diseases• IBD: Disease Activity Assessment• IBD: Epidemiology• IBD: Natural History and Outcomes
Liver & Biliary• Complications of Cirrhosis and Portal Hypertension• Hepatic Fibrosis, Diagnosis and Treatment
Microbiome & Microbial Diseases in the Gastrointestinal Tract• Basic and Translational: Microbiome and
Microbial Diseases of the GI Tract
Neurogastroenterology & Motility• Anorectal Dysmotility (Including Fecal Incontinence,
Dyssynergia and Pelvic Floor Disorders)• Epithelial Junctions and Barrier Function• Functional Dyspepsia, Nausea and Vomiting• Pediatric Functional and Motility Disorders• The Microbiome-Gut-Brain Axis in Health and Disease
Obesity, Metabolism & Nutrition• Endoscopic and Surgical Therapies of Obesity and Metabolic
Disorders• Intestinal Failure/Short Gut: Basic and Clinical• Microbial Regulation of Host Metabolic and Energy
Homeostasis• Nutritional Support: Enteral and Parenteral
Pancreatic Disorders• Pancreatic Cancer: Risk Factors, Biology, Diagnosis and
Clinical Therapeutics• Pancreatic Cystic Neoplasms, IPMN and Neuroendocrine
Tumors
Poster SessionsPoster Sessions9:30 a.m.–4 p.m.
AGA will feature more than 2,000 poster presentations at DDW 2018. Posters are displayed each day from 9:30 a.m. to 4 p.m. in Hall C. Presenters will be at their posters to answer questions from noon until 2 p.m. on the day their posters are scheduled.
2120
Sunday AGA Poster Tour Topics:Basic Science MicrobiomeColon Cancer ScreeningIBDPancreatic Diseases
Sunday DDW ePosters Theater Topics:ERCPHPB NAFLD
AGA Poster Tours Subject-matter experts from AGA will lead daily tours of the Poster Hall, highlighting the most significant research. These complimentary guided tours provide attendees with discussion and networking opportunities with leaders and presenters.Saturday AGA Poster Tour Topics:EoE and GERDIBSObesity and Nutrition
DDW ePosters Theater DDW will offer complimentary ePoster presentations in the DDW ePosters Theater. Daily topical presentations, curated by society experts, will highlight the latest science featured in the Poster Hall in a small theater setting.Saturday ePosters Theater Topics:ColonoscopyHepatitis BIBD
9:30 a.m.–4 p.m.
22 23
Monday, June 4Basic & Clinical Intestinal Disorders• Celiac Disease and Gluten Related Disorders II• Food Intolerances, Allergy and Sensitivities
Cellular & Molecular Gastroenterology• GI Stem Cells and Tissue Engineering• Physiology and Cell Biology of GI Tissues
Clinical Practice• Epidemiology and Outcomes of GI Bleeding• Population Colorectal Cancer Screening• Systematic Reviews
Esophageal, Gastric & Duodenal Disorders• Esophageal Motility and Dysmotility• Mucosal Defense, Secretion, Injury, Repair and Healing• Peptic Ulcer Disease and Non-Variceal UGI Bleeding
Gastrointestinal Oncology• Biomarkers for Detection, Treatment and Prognosis of GI
Cancers II• Cancer Prevention and Chemoprevention I• Carcinoid and Neuroendocrine Neoplasms: Biology,
Diagnosis and Clinical Therapeutics• Epidemiology I• Esophageal and Junctional Neoplasms: Precursor Lesions,
Biology, Diagnosis and Clinical Therapeutics I• Familial Cancer Syndromes and Cancer Genetics• Population Health Screening: Colorectal Cancer, Esophageal
Cancer, Hepatocellular Carcinoma, Other Screening• Translational and Targeted Therapies for GI Cancers
Growth, Development & Child Health• Pediatric Functional and Motility Disorders II
Imaging, Endoscopy & Advanced Technology• Diagnostic and Therapeutic Applications II• Imaging and Therapeutic Intervention in Obesity and
Metabolic Disease
Immunology, Microbiology & Inflammatory Bowel Diseases• IBD: Practice Management/Quality of Care/Quality
Assurance• IBD: Quality of Life/Psychosocial Care• IBD: Therapeutic Monitoring• IBD: Uncontrolled Therapeutic Observations in Humans
(Non-Biologic)
Liver & Biliary• Clinical Hepatitis: Etiology, Diagnosis and Natural History• Clinical Hepatitis: Prevention and Treatment• Metabolic and Genetic Liver Disease• Molecular Mechanisms of Growth and Development of the
GI Tract, Liver and Pancreas• Pharmacoeconomics and Cost-Effectiveness Analysis of
Liver Disease
Microbiome & Microbial Diseases in the Gastrointestinal Tract• Highlights of Microbiome Research II
Neurogastroenterology & Motility• Brain-Gut Axis (Including Neuroimaging, Vagal Pathways and
Neurobiology of Satiety, Obesity and Metabolic Disorders)• Constipation and Other Functional Colonic Syndromes• Development of the Enteric Nervous System• Enteric Neurobiology: Cell and Molecular Biology (Including
Neurons, Glia, ICC, Smooth Muscle and Stem Cells)• Enteric Neuromuscular Biology: Pharmacology• Sensory Neurobiology Including Visceral Nociception/
Pain and Neuroimmunology (Neurogenic Inflammation and Interactions With the Microbiome)
Obesity, Metabolism & Nutrition• Diet and the Gut Microbiome• Food Intolerance, Allergy and Sensitivities• Role of the Gut Microbiome in Immune and Inflammatory
Diseases
Pancreatic Disorders• Clinical Acute Pancreatitis II• Clinical Chronic Pancreatitis• Pancreatic Disorders: Endoscopy and Imaging
Tuesday, June 5Basic & Clinical Intestinal Disorders• Diarrheal Diseases, Bacterial Overgrowth, Drug Induced and
Other Enteropathies• In Vivo and Organoid Models of Gastrointestinal Disorders• Inflammation and GI Cancers• Stem Cell Biology
Cellular & Molecular Gastroenterology• Cell and Molecular Biology of Intestinal Disorders• Cell Signaling in Inflammation, Injury and Repair
Clinical Practice• IBD Epidemiology and Clinical Outcomes• Patient Reported Outcomes• Process Improvement
Esophageal, Gastric & Duodenal Disorders• Barrett's Esophagus: Diagnosis, Management and
Surveillance• Functional Dyspepsia, Nausea and Vomiting• Helicobacter pylori: Host Response and Pathogenesis• Helicobacter pylori: Treatment and Antimicrobial Resistance
Gastrointestinal Oncology• Biomarkers for Detection, Treatment and Prognosis of GI
Cancers III• Cancer Prevention and Chemoprevention II• Epidemiology II• Esophageal and Junctional Neoplasms: Precursor Lesions,
Biology, Diagnosis and Clinical Therapeutics II• Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis
and Therapy II• Liver and Biliary Carcinoma: Management, Etiology,
Diagnosis and Natural History• Molecular Mechanisms and Pathways in Carcinogenesis
and Metastasis: Bench to Bedside II
Growth, Development & Child Health• Clinical Pediatric Gastroenterology: Other
Imaging, Endoscopy & Advanced Technology• Enhanced Endoscopic Imaging Including Molecular Imaging;
Spectroscopy and Fluorescence Imaging; and Optical Coherence Tomography
• Imaging Techniques Including Comparative Studies and Efficacy
Immunology, Microbiology & Inflammatory Bowel Diseases• Animal Models: Pre-Clinical Treatment of Intestinal
Inflammation• Epithelial Cell Function in Inflammation• IBD: Cytokines, Signaling and Receptors• IBD: Genomics and Gene Function
• IBD: Innate and Adaptive Lymphoid Activation and Regulation
• IBD: Microbiome• Intestinal Inflammation, Fibrosis and Regeneration• Microbial-Based Therapy• Mucosal Innate Immune Function and Innate Host Defense• Pediatric IBD: Clinical and Translational Studies
Liver & Biliary• Extraintestinal Interactions of the Gut Microbiome• Fatty Liver Diseases, ASH and NASH• Liver and Biliary Carcinoma: Management, Etiology,
Diagnosis and Natural History
Microbiome & Microbial Diseases in the Gastrointestinal Tract• Clinical and Translational: Microbiome and Microbial
Diseases in the Gastrointestinal Tract
Neurogastroenterology & Motility• Esophageal Motility and Dysmotility• Irritable Bowel Syndrome: Clinical• Oropharyngeal Dysmotility
Obesity, Metabolism & Nutrition• Imaging and Therapeutic Intervention in Obesity and
Metabolic Disease• Nutrient Absorption and Intestinal Epithelial Function• Obesity: Pre-Clinical and Clinical• Regulation of Food Intake, Energy Expenditure and
Metabolic Function• Vitamins and Micronutrients: Basic and Clinical
Pancreatic Disorders• Pancreatic Cancer: Risk Factors, Biology, Diagnosis and
Clinical Therapeutics II• Pancreatic Disorders: Endoscopy and Imaging II• Pancreatic Genetics, Epigenetics, Physiology, Cell Biology
and Pathobiology• Pancreatitis: Inflammation, Fibrogenesis and Immunology• The Microbiome in Pancreatitis, Pancreatic Malabsorption
and Pancreatic Tumorigenesis
Poster Sessions9:30 a.m.–4 p.m.
Poster Sessions
2322
Monday AGA Poster Tour Topics:InflammationInjury, Repair and Barrier FunctionStem Cell Biology
Tuesday AGA Poster Tour Topics:Clinical MicrobiomeIBDIBS
Monday DDW ePosters Theater Topics:Bariatric EndoscopyEsophagus and GastricIBS
Tuesday DDW ePosters Theater Topics:Hepatitis C PancreasSmall Bowel/Colorectal
9:30 a.m.–4 p.m.
4930 Del Ray Ave.Bethesda, MD 20814
Look for these in all of our attendee resources as you plan for the meeting.
DDW Tracks
They include:
1 Basic Science
2 Biliary Tract Diseases
3 Clinical Practice
4 Colorectal Diseases
5 Education and Training
6 Esophageal Diseases
7 Functional GI and Motility Disorders
Health Care Delivery and Disparities8
9 Inflammatory Bowel Diseases
10 Liver Diseases and Transplantation
11 Microbiome in Gastrointestinal and Liver Diseases
12 Obesity and Nutrition
13 Pancreatic Diseases
14 Pediatric GI
15 Practice Management
16 Stomach and Small Bowel Disorders
17 Technologies and Procedural Innovations
Seventeen tracks provide attendees with the ability to search all 2018 sessions by topic or theme across all societies. Learn moreat www.ddw.org/tracks.
17tracks
top related